Copyright Reports & Markets. All rights reserved.

Global Atropine Market Research Report 2019

Request for Sample of this report
Buy now

Table of Contents

    Executive Summary

      1 Atropine Market Overview

      • 1.1 Product Overview and Scope of Atropine
      • 1.2 Atropine Segment by Type
        • 1.2.1 Global Atropine Production Growth Rate Comparison by Type (2014-2025)
        • 1.2.2 Injection
        • 1.2.3 Drop
        • 1.2.4 Gel
      • 1.3 Atropine Segment by Application
        • 1.3.1 Atropine Consumption Comparison by Application (2014-2025)
        • 1.3.2 Gastrointestinal
        • 1.3.3 Ophthalmology
        • 1.3.4 Other
      • 1.3 Global Atropine Market by Region
        • 1.3.1 Global Atropine Market Size Region
        • 1.3.2 North America Status and Prospect (2014-2025)
        • 1.3.3 Europe Status and Prospect (2014-2025)
        • 1.3.4 China Status and Prospect (2014-2025)
        • 1.3.5 Japan Status and Prospect (2014-2025)
        • 1.3.6 Southeast Asia Status and Prospect (2014-2025)
        • 1.3.7 India Status and Prospect (2014-2025)
      • 1.4 Global Atropine Market Size
        • 1.4.1 Global Atropine Revenue (2014-2025)
        • 1.4.2 Global Atropine Production (2014-2025)

      2 Global Atropine Market Competition by Manufacturers

      • 2.1 Global Atropine Production Market Share by Manufacturers (2014-2019)
      • 2.2 Global Atropine Revenue Share by Manufacturers (2014-2019)
      • 2.3 Global Atropine Average Price by Manufacturers (2014-2019)
      • 2.4 Manufacturers Atropine Production Sites, Area Served, Product Types
      • 2.5 Atropine Market Competitive Situation and Trends
        • 2.5.1 Atropine Market Concentration Rate
        • 2.5.2 Atropine Market Share of Top 3 and Top 5 Manufacturers
        • 2.5.3 Mergers & Acquisitions, Expansion

      3 Global Atropine Production Market Share by Regions

      • 3.1 Global Atropine Production Market Share by Regions
      • 3.2 Global Atropine Revenue Market Share by Regions (2014-2019)
      • 3.3 Global Atropine Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.4 North America Atropine Production
        • 3.4.1 North America Atropine Production Growth Rate (2014-2019)
        • 3.4.2 North America Atropine Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.5 Europe Atropine Production
        • 3.5.1 Europe Atropine Production Growth Rate (2014-2019)
        • 3.5.2 Europe Atropine Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.6 China Atropine Production (2014-2019)
        • 3.6.1 China Atropine Production Growth Rate (2014-2019)
        • 3.6.2 China Atropine Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.7 Japan Atropine Production (2014-2019)
        • 3.7.1 Japan Atropine Production Growth Rate (2014-2019)
        • 3.7.2 Japan Atropine Production, Revenue, Price and Gross Margin (2014-2019)

      4 Global Atropine Consumption by Regions

      • 4.1 Global Atropine Consumption by Regions
      • 4.2 North America Atropine Consumption (2014-2019)
      • 4.3 Europe Atropine Consumption (2014-2019)
      • 4.4 China Atropine Consumption (2014-2019)
      • 4.5 Japan Atropine Consumption (2014-2019)

      5 Global Atropine Production, Revenue, Price Trend by Type

      • 5.1 Global Atropine Production Market Share by Type (2014-2019)
      • 5.2 Global Atropine Revenue Market Share by Type (2014-2019)
      • 5.3 Global Atropine Price by Type (2014-2019)
      • 5.4 Global Atropine Production Growth by Type (2014-2019)

      6 Global Atropine Market Analysis by Applications

      • 6.1 Global Atropine Consumption Market Share by Application (2014-2019)
      • 6.2 Global Atropine Consumption Growth Rate by Application (2014-2019)

      7 Company Profiles and Key Figures in Atropine Business

      • 7.1 C²PHARMA
        • 7.1.1 C²PHARMA Atropine Production Sites and Area Served
        • 7.1.2 Atropine Product Introduction, Application and Specification
        • 7.1.3 C²PHARMA Atropine Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.1.4 Main Business and Markets Served
      • 7.2 RESONANCE LABORATORIES
        • 7.2.1 RESONANCE LABORATORIES Atropine Production Sites and Area Served
        • 7.2.2 Atropine Product Introduction, Application and Specification
        • 7.2.3 RESONANCE LABORATORIES Atropine Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.2.4 Main Business and Markets Served
      • 7.3 ROLABO OUTSOURCING
        • 7.3.1 ROLABO OUTSOURCING Atropine Production Sites and Area Served
        • 7.3.2 Atropine Product Introduction, Application and Specification
        • 7.3.3 ROLABO OUTSOURCING Atropine Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.3.4 Main Business and Markets Served
      • 7.4 Minsheng Group
        • 7.4.1 Minsheng Group Atropine Production Sites and Area Served
        • 7.4.2 Atropine Product Introduction, Application and Specification
        • 7.4.3 Minsheng Group Atropine Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.4.4 Main Business and Markets Served
      • 7.5 CR Double-Crane
        • 7.5.1 CR Double-Crane Atropine Production Sites and Area Served
        • 7.5.2 Atropine Product Introduction, Application and Specification
        • 7.5.3 CR Double-Crane Atropine Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.5.4 Main Business and Markets Served
      • 7.6 HENAN PURUI
        • 7.6.1 HENAN PURUI Atropine Production Sites and Area Served
        • 7.6.2 Atropine Product Introduction, Application and Specification
        • 7.6.3 HENAN PURUI Atropine Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.6.4 Main Business and Markets Served
      • 7.7 Albany Molecular Research
        • 7.7.1 Albany Molecular Research Atropine Production Sites and Area Served
        • 7.7.2 Atropine Product Introduction, Application and Specification
        • 7.7.3 Albany Molecular Research Atropine Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.7.4 Main Business and Markets Served
      • 7.8 Alchem International
        • 7.8.1 Alchem International Atropine Production Sites and Area Served
        • 7.8.2 Atropine Product Introduction, Application and Specification
        • 7.8.3 Alchem International Atropine Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.8.4 Main Business and Markets Served
      • 7.9 SAURAV CHEMICALS
        • 7.9.1 SAURAV CHEMICALS Atropine Production Sites and Area Served
        • 7.9.2 Atropine Product Introduction, Application and Specification
        • 7.9.3 SAURAV CHEMICALS Atropine Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.9.4 Main Business and Markets Served
      • 7.10 Katsura Chemical
        • 7.10.1 Katsura Chemical Atropine Production Sites and Area Served
        • 7.10.2 Atropine Product Introduction, Application and Specification
        • 7.10.3 Katsura Chemical Atropine Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.10.4 Main Business and Markets Served
      • 7.11 Hangzhou Vega
      • 7.12 Wuhan senwayer century

      8 Atropine Manufacturing Cost Analysis

      • 8.1 Atropine Key Raw Materials Analysis
        • 8.1.1 Key Raw Materials
        • 8.1.2 Price Trend of Key Raw Materials
        • 8.1.3 Key Suppliers of Raw Materials
      • 8.2 Proportion of Manufacturing Cost Structure
      • 8.3 Manufacturing Process Analysis of Atropine
      • 8.4 Atropine Industrial Chain Analysis

      9 Marketing Channel, Distributors and Customers

      • 9.1 Marketing Channel
        • 9.1.1 Direct Marketing
        • 9.1.2 Indirect Marketing
      • 9.2 Atropine Distributors List
      • 9.3 Atropine Customers

      10 Market Dynamics

      • 10.1 Market Trends
      • 10.2 Opportunities
      • 10.3 Market Drivers
      • 10.4 Challenges
      • 10.5 Influence Factors

      11 Global Atropine Market Forecast

      • 11.1 Global Atropine Production, Revenue Forecast
        • 11.1.1 Global Atropine Production Growth Rate Forecast (2019-2025)
        • 11.1.2 Global Atropine Revenue and Growth Rate Forecast (2019-2025)
        • 11.1.3 Global Atropine Price and Trend Forecast (2019-2025)
      • 11.2 Global Atropine Production Forecast by Regions (2019-2025)
        • 11.2.1 North America Atropine Production, Revenue Forecast (2019-2025)
        • 11.2.2 Europe Atropine Production, Revenue Forecast (2019-2025)
        • 11.2.3 China Atropine Production, Revenue Forecast (2019-2025)
        • 11.2.4 Japan Atropine Production, Revenue Forecast (2019-2025)
      • 11.3 Global Atropine Consumption Forecast by Regions (2019-2025)
        • 11.3.1 North America Atropine Consumption Forecast (2019-2025)
        • 11.3.2 Europe Atropine Consumption Forecast (2019-2025)
        • 11.3.3 China Atropine Consumption Forecast (2019-2025)
        • 11.3.4 Japan Atropine Consumption Forecast (2019-2025)
      • 11.4 Global Atropine Production, Revenue and Price Forecast by Type (2019-2025)
      • 11.5 Global Atropine Consumption Forecast by Application (2019-2025)

      12 Research Findings and Conclusion

        13 Methodology and Data Source

        • 13.1 Methodology/Research Approach
          • 13.1.1 Research Programs/Design
          • 13.1.2 Market Size Estimation
          • 13.1.3 Market Breakdown and Data Triangulation
        • 13.2 Data Source
          • 13.2.1 Secondary Sources
          • 13.2.2 Primary Sources
        • 13.3 Author List

        Atropine is a medication to treat certain types of nerve agent and pesticide poisonings as well as some types of slow heart rate and to decrease saliva production during surgery. It is typically given intravenously or by injection into a muscle. Eye drops are also available which are used to treat uveitis and early amblyopia. The intravenous solution usually begins working within a minute and lasts half an hour to an hour. Large doses may be required to treat some poisonings.
        Atropine is a medication to treat certain types of nerve agent and pesticide poisonings as well as some types of slow heart rate and to decrease saliva production during surgery. It is typically given intravenously or by injection into a muscle. Eye drops are also available which are used to treat uveitis and early amblyopia. The intravenous solution usually begins working within a minute and lasts half an hour to an hour. Large doses may be required to treat some poisonings.

        Atropine industry is relatively fragmented, manufacturers are mostly in the North America, Europe and Asia, and China market production volume accounted for more than 25.43% of the total production volume of global Atropine in 2017. C²PHARMA is the world leading manufacturer in global Atropine market with the market share of 9.19%, in terms of revenue, followed by RESONANCE LABORATORIES, ROLABO OUTSOURCING, Minsheng Group and CR Double-Crane.

        Compared to 2016, Atropine market decreased revenue by 5.69 percent to $549.60 million worldwide in 2017 from $582.76 million in 2016. As for the volume segment, global Atropine production decreased to 3862.8 Kg from 4247.4 Kg in 2013. Due to low prices, small profit margins and a relatively narrow market, many companies have abandoned production of atropine, and a shortage of atropine has appeared in the market. This is the result of long-term effects of market behavior.

        The average price of Atropine will fall further. The product average price declined in the past few years due to its cheap drug properties, and the average price will keep this trend in the few future years due to market vicious circle.

        The global Atropine market is valued at 550 million US$ in 2018 is expected to reach 480 million US$ by the end of 2025, growing at a CAGR of -1.7% during 2019-2025.
        This report focuses on Atropine volume and value at global level, regional level and company level. From a global perspective, this report represents overall Atropine market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.
        At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.

        The following manufacturers are covered:
        C²PHARMA
        RESONANCE LABORATORIES
        ROLABO OUTSOURCING
        Minsheng Group
        CR Double-Crane
        HENAN PURUI
        Albany Molecular Research
        Alchem International
        SAURAV CHEMICALS
        Katsura Chemical
        Hangzhou Vega
        Wuhan senwayer century

        Segment by Regions
        North America
        Europe
        China
        Japan

        Segment by Type
        Injection
        Drop
        Gel

        Segment by Application
        Gastrointestinal
        Ophthalmology
        Other

        Buy now